Physician profile
Ira D Horowitz
NPI 1780682278
$7,443.45
in general payments reported to CMS, 2019-2025
43 companies · $1,220 in 2025
The $1,220 reported for 2025 was more than what 80% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $744 · 2020: $596 · 2021: $872 · 2022: $1,177 · 2023: $1,249 · 2024: $1,585 · 2025: $1,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,054.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,054.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,779.04 | 2019-2025 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $1,747.22 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Inari Medical, INC. | $365.85 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mylan Specialty L.P. | $342.55 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $337.83 | 2019-2025 | Dupixent |
| Philips North America LLC | $333.89 | 2019-2024 | (Ak6) Vest Therapy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $258.91 | 2019-2025 | Ofev |
| Genzyme Corporation | $251.07 | 2019-2024 | |
| United Therapeutics Corporation | $242.55 | 2019-2023 | Tyvaso |
| Insmed, INC. | $212.84 | 2019-2025 | Arikayce, Brinsupri |
| Amgen INC. | $188.18 | 2022-2025 | Tezspire |
| Verona Pharma, INC. | $137.93 | 2025 | Ohtuvayre |
| Harmony Biosciences LLC | $119.30 | 2020-2024 | Wakix |
| Actelion Pharmaceuticals US, INC. | $104.05 | 2019-2024 | Opsumit, Uptravi |
| Grifols USA, LLC | $82.83 | 2020-2023 | Prolastin-C Liquid |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $80.88 | 2021-2025 | Aralast |
| Advanced Respiratory, INC | $69.06 | 2020-2021 | |
| Genentech USA, INC. | $66.85 | 2021-2025 | Xolair |
| Axsome Therapeutics, INC. | $62.26 | 2024-2025 | Sunosi |
| Jazz Pharmaceuticals INC. | $61.33 | 2020-2023 | Xywav |
| Baxter Healthcare | $59.11 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Pfizer INC. | $54.97 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $53.18 | 2020-2022 | |
| Electromed, INC. | $51.79 | 2019-2023 | Smartvest |
| Pulmonx Corporation | $33.85 | 2022-2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Avadel Cns Pharmaceuticals, LLC | $33.66 | 2024 | Lumryz |
| Viatris Specialty LLC | $28.67 | 2025 | Yupelri |
| Paratek Pharmaceuticals, INC. | $28.48 | 2019-2024 | Nuzyra |
| Vapotherm INC | $27.60 | 2025 | Vapotherm |
| Inogen, INC. | $25.34 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Novo Nordisk INC | $21.26 | 2025 | Wegovy |
| Inspire Medical Systems, INC. | $18.45 | 2024 | Inspire |
| Abbvie INC. | $18.06 | 2025 | |
| Mallinckrodt Hospital Products INC. | $16.92 | 2022 | |
| Pharming Healthcare, INC. | $16.72 | 2023 | Ruconest |
| Resmed Corp | $15.19 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.52 | 2020 | |
| Merck Sharp & Dohme LLC | $13.99 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.92 | 2022 | |
| Circassia INC. | $13.89 | 2019 | |
| Shire North American Group INC | $13.67 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.02 | 2019 | |
| Horizon Therapeutics Plc | $12.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ira Horowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.